ImmunityBio, Inc. Common Stock IBRX

$10.29 +10.83% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-04 View →
8-K 8-K 2026-08-04 View →
8-K 8-K 2026-07-30 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-01 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-10 View →
4 FORM 4 2026-06-10 View →
4 FORM 4 2026-06-10 View →
4 FORM 4 2026-06-10 View →
4 FORM 4 2026-06-10 View →
4 FORM 4 2026-06-10 View →
8-K 8-K 2026-06-10 View →
4 FORM 4 2026-06-05 View →
8-K 8-K 2026-05-18 View →
10-Q 10-Q 2026-05-07 View →
8-K 8-K 2026-05-07 View →
DEF 14A DEF 14A 2026-04-30 View →
8-K 8-K 2026-04-09 View →
8-K 8-K 2026-04-06 View →
4 FORM 4 2026-04-02 View →
8-K 8-K 2026-03-31 View →
4 FORM 4 2026-02-26 View →
4 FORM 4 2026-02-24 View →
4 FORM 4 2026-02-24 View →
4 FORM 4 2026-02-24 View →
4 FORM 4 2026-02-24 View →
4 FORM 4 2026-02-24 View →
4 FORM 4 2026-02-24 View →
10-K 10-K 2026-02-23 View →
8-K 8-K 2026-02-23 View →
8-K 8-K 2026-02-18 View →
4 FORM 4 2026-02-12 View →
4 FORM 4 2026-02-12 View →
4 FORM 4 2026-02-12 View →
4 FORM 4 2026-02-12 View →
8-K 8-K 2026-01-26 View →
4 FORM 4 2026-01-21 View →
4 FORM 4 2026-01-21 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$10.29
Market Cap
$10.90 billion
52-Week Range
$1.95 – $12.43
Average Volume
11.33 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.